Consistent with the current findings, hepatic NF-κB p65 protein level was significantly increased in the T2DM-NASH group (Fig. 3K and S; Fig. 4C) compared with the control group (Fig. 3I and M) and the control-cele group(Fig. 3J and N). The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.